The previous page is sending you to https://www.moneycontrol.com/news/business/companies/top-selling-drugs-face-patent-expiration-between-2018-and-2024-sales-worth-251-bn-at-stake-report-2604401.html.

 If you do not want to visit that page, you can return to the previous page.